
Manzo Pharmaceuticals, Inc. Share · US56510D1063 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Manzo Pharmaceuticals, Inc.
No Price
Closing Price OTC 30.04.2026:
0,00001 USD
30.04.2026 20:00
Current Prices from Manzo Pharmaceuticals, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
MNZO
|
USD
|
30.04.2026 20:00
|
0,00001 USD
| 0,00 USD |
Company Profile for Manzo Pharmaceuticals, Inc. Share
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.
Company Data
Name Manzo Pharmaceuticals, Inc.
Company Manzo Pharmaceuticals, Inc.
Website
https://www.lactofreedom.com
Primary Exchange
UTC
ISIN US56510D1063
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Kenneth Manzo
Country United States of America
Currency USD
Employees 0,0 T
Address PO Box 107, 18337 Milford
IPO Date 1998-12-31
Stock Splits
| Date | Split |
|---|---|
| 17.09.2014 | 1:10 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | MNZO |
More Shares
Investors who hold Manzo Pharmaceuticals, Inc. also have the following shares in their portfolio:
